Scarsdale, NY, United States of America

Danish Saleheen

This inventor holds 1 USPTO granted patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Danish Saleheen. Retrieved from https://idiyas.com/inventor/danish-saleheen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Danish Saleheen: Innovator in Cerebrovascular Disease Treatment

Introduction

Danish Saleheen is a notable inventor based in Scarsdale, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of cerebrovascular diseases. His innovative work has led to the development of a patent that addresses critical health issues.

Latest Patents

Danish Saleheen holds a patent titled "Treatment Of Cerebrovascular Disease With Neurogenic Locus Notch Homolog Protein 3 (NOTCH3) Agents." This patent represents his commitment to advancing medical treatments and improving patient outcomes.

Career Highlights

Danish Saleheen is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to work on groundbreaking research and development projects. His role at the company allows him to collaborate with other talented professionals in the field.

Collaborations

Some of his notable coworkers include Juan Rodriguez-Flores and Alan Shuldiner. Their collective expertise contributes to the innovative environment at Regeneron Pharmaceuticals.

Conclusion

Danish Saleheen's work in the treatment of cerebrovascular diseases exemplifies the impact of innovation in medicine. His contributions are paving the way for future advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…